Advec, Inc.
Records under this name other than patents Advec, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,132,290 | Recombinase-based system for combustion of adenovirus vectors Term ended Term ended Mar 23, 2019 · From the USPTO record | Term ended | Term ended Mar 23, 2019 | From the USPTO record |
| US 6,379,943 | High-efficiency Cre/loxp based system for construction of adenovirus vectors Term ended Term ended Mar 5, 2019 · From the USPTO record | Term ended | Term ended Mar 5, 2019 | From the USPTO record |
| US 6,140,087 | Adenovirus vectors for gene therapy Term ended Term ended Oct 31, 2017 · From the USPTO record | Term ended | Term ended Oct 31, 2017 | From the USPTO record |
| US 6,120,764 | Adenoviruses for control of gene expression Term ended Term ended Sep 19, 2017 · From the USPTO record | Term ended | Term ended Sep 19, 2017 | From the USPTO record |
| US 6,855,534 | Enhanced system for construction of adenovirus vectors Lapsed on the fee record Ended Feb 15, 2017 · From the USPTO record | Lapsed on the fee record | Ended Feb 15, 2017 | From the USPTO record |
| US 6,080,569 | Adenovirus vectors generated from helper viruses and helper-dependent vectors Term ended Term ended Sep 25, 2016 · From the USPTO record | Term ended | Term ended Sep 25, 2016 | From the USPTO record |
| US 7,045,347 | Helper dependent adenovirus vectors based on integrase family site-specific recombinases Term ended Term ended Mar 2, 2016 · From the USPTO record | Term ended | Term ended Mar 2, 2016 | From the USPTO record |
| US 6,974,694 | Adenoviruses for control of gene expression Term ended Term ended Oct 27, 2015 · From the USPTO record | Term ended | Term ended Oct 27, 2015 | From the USPTO record |
| US 7,189,561 | Production of adenovirus vectors with reduced levels of replication competent adenovirus contamination Lapsed on the fee record Ended Mar 13, 2015 · From the USPTO record | Lapsed on the fee record | Ended Mar 13, 2015 | From the USPTO record |
| US 7,135,187 | System for production of helper dependent adenovirus vectors based on use of endonucleases Lapsed on the fee record Ended Nov 14, 2014 · From the USPTO record | Lapsed on the fee record | Ended Nov 14, 2014 | From the USPTO record |